Ulrich Ernst
Technik-/Wissenschafts-/F&E-Leiter bei PROKIDNEY CORP.
Profil
Ulrich Ernst is currently the Executive Vice President-Technical Operations at ProKidney Corp.
Prior to his current position, he held the role of Senior Vice President-Technical Operations at Iovance Biotherapeutics, Inc. from 2019 to 2024.
Before that, he served as the Chief Operating Officer at Amunix Pharmaceuticals, Inc. and as the Vice President-Operations at Cytovance Biologics, Inc. Dr. Ernst holds a doctorate degree from Lehigh University and an undergraduate degree from the University of Minnesota.
Aktive Positionen von Ulrich Ernst
| Unternehmen | Position | Beginn |
|---|---|---|
| PROKIDNEY CORP. | Technik-/Wissenschafts-/F&E-Leiter | 25.03.2024 |
Ehemalige bekannte Positionen von Ulrich Ernst
| Unternehmen | Position | Ende |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2024 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Geschäftsführer | - |
Cytovance Biologics, Inc.
 Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Geschäftsführer | - |
Ausbildung von Ulrich Ernst
| University of Minnesota | Undergraduate Degree |
| Lehigh University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| PROKIDNEY CORP. | Health Technology |
| IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |
